Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
WOCKPHARMA Stock Analysis
Views
Red Flags
Positive
Strong EPS growth and above median growth of industry
Negative
Stock is fairly expensive with negative EPS on a trailing 12-month basis
Low and declining ROE
Low revenue growth and lower than median growth of industry
High and increasing Debt to Equity
Low dividend yield
Neutral
Low operating margin but improving trend
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
WOCKPHARMA Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
WOCKPHARMA Bulk, Block & Insider Trades
WOCKPHARMA Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Rights issue
Others
Rights issue(3 new shares @ 225 INR for 10 existing shares) Ex-date: 8th Mar 2022 Announced on: 3rd Mar 2022
Complex capital changeA constituent event of a complex capital change comprising of a sub-division of equity shares from Rs.10 to Rs.5 each and bonus shares in the ratio of one share for every two existing shares. Ex-date: 29th Apr 2004 Announced on: 12th Feb 2004
MergerEquity shares alloted to the shareholders of erstwhile Wockhardt Vetiranary Ltd. pursuant ot the Scheme of Amalgamation. Ex-date: 1st Jan 2001 Announced on: 31st Dec 2000
Company Profile
Wockhardt Limited is a research-based global pharmaceutical and biotech company. The Company is engaged in the pharmaceutical business. It focuses on the unmet need for antibacterial drugs that are effective against the menace of untreatable superbugs. It manufactures and supplies branded and generi... Read More
Key personnel
Dr. Habil Fakhruddin KhorakiwalaD
Executive Chairman of the Board, Founder
Mr. Deepak Madnani
Chief Financial Officer
Ms. Rashmi Mamtura
Compliance Officer, Company Secretary
Dr. Murtaza Habil KhorakiwalaD
Managing Director, Executive Director
Dr. Huzaifa Habil KhorakiwalaD
Executive Director
Ms. Zahabiya Habil KhorakiwalaD
Non-Executive Non- Independent Director
Mr. Om Prakash BhattD
Additional Non-Executive Independent Director
Ms. Amelia FernandesD
Non-Executive Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Wockhardt Ltd.?
The current share price of Wockhardt Ltd. is ₹ 1,405.18 as of 09 Jan 2026.
What is the PE ratio of Wockhardt Ltd.?
The Price-to-Earnings (PE) ratio of Wockhardt Ltd. is - as of the latest financial data.
What is the ROE and ROCE of Wockhardt Ltd.?
Wockhardt Ltd. has a Return on Equity (ROE) of -11.83% and a Return on Capital Employed (ROCE) of 2.81% as per the latest financial reports.
What is the market cap of Wockhardt Ltd.?
The market capitalization of Wockhardt Ltd. stands at ₹ 22,833.10 Cr.
What is the dividend yield of Wockhardt Ltd.?
The dividend yield of Wockhardt Ltd. is 0.00% based on the current market price.
What is the RSI of Wockhardt Ltd.?
The Relative Strength Index (RSI) of Wockhardt Ltd. is 49.45.
What is the FII and DII holding in Wockhardt Ltd.?
Foreign Institutional Investors (FII) hold 7.10% and Domestic Institutional Investors (DII) hold 8.55% of Wockhardt Ltd. shares.
What sector does Wockhardt Ltd. belong to?
Wockhardt Ltd. operates in the Healthcare sector.
What is the beta of Wockhardt Ltd. stock?
The beta of Wockhardt Ltd. stock is 1.55, indicating its volatility relative to the broader market.
